Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Interleukin 6 regulates psoriasiform inflammation–associated thrombosis
Yunmei Wang, … , Thomas S. McCormick, Nicole L. Ward
Yunmei Wang, … , Thomas S. McCormick, Nicole L. Ward
Published December 8, 2016
Citation Information: JCI Insight. 2016;1(20):e89384. https://doi.org/10.1172/jci.insight.89384.
View: Text | PDF
Research Article Cardiology Dermatology

Interleukin 6 regulates psoriasiform inflammation–associated thrombosis

  • Text
  • PDF
Abstract

Psoriasis patients are at increased risk of heart attack and stroke and have elevated MRP8/14 levels that predict heart attack. The KC-Tie2 psoriasiform mouse model exhibits elevated MRP8/14 and is prothrombotic. Mrp14–/– mice, in contrast, are protected from thrombosis, but, surprisingly, KC-Tie2xMrp14–/– mice remain prothrombotic. Treating KC-Tie2xMrp14–/– mice with anti–IL-23p19 antibodies reversed the skin inflammation, improved thrombosis, and decreased IL-6. In comparison, IL-6 deletion from KC-Tie2 animals improved thrombosis despite sustained skin inflammation, suggesting that thrombosis improvements following IL-23 inhibition occur secondary to IL-6 decreases. Psoriasis patient skin has elevated IL-6 and IL-6 receptor is present in human coronary atheroma, supporting a link between skin and distant vessel disease in patient tissue. Together, these results identify a critical role for skin-derived IL-6 linking skin inflammation with thrombosis, and shows that in the absence of IL-6 the connection between skin inflammation and thrombosis comorbidities is severed.

Authors

Yunmei Wang, Jackelyn B. Golden, Yi Fritz, Xiufen Zhang, Doina Diaconu, Maya I. Camhi, Huiyun Gao, Sean M. Dawes, Xianying Xing, Santhi K. Ganesh, Johann E. Gudjonsson, Daniel I. Simon, Thomas S. McCormick, Nicole L. Ward

×

Figure 1

MRP14 deficiency in KC-Tie2 mice fails to resolve the prothrombotic phenotype or improve skin inflammation.

Options: View larger image (or click on image) Download as PowerPoint
MRP14 deficiency in KC-Tie2 mice fails to resolve the prothrombotic phen...
(A) Occlusion times (minutes) following rose bengal–induced photochemical injury of the carotid artery in control (n = 18), KC-Tie2 (n = 15), Mrp14–/– (n = 17), and KC-Tie2xMrp14–/– (n = 16) mice. (B) Gross phenotype of KC-Tie2xMrp14–/– mice in comparison with control, KC-Tie2, and Mrp14–/– mice. (C) Representative images of H&E-stained dorsal skin sections of control, KC-Tie2, Mrp14–/–, and KC-Tie2xMrp14–/– mice. Scale bar: 25 μm. (D) Quantification of epidermal thickness (μm) of H&E-stained dorsal skin sections of control (n = 9), KC-Tie2 (n = 9), Mrp14–/– (n = 13), and KC-Tie2xMrp14–/– (n = 12) mice. Values shown represent the mean ± SEM. Each dot represents 1 individual mouse. Data were analyzed using a Student’s t test. P values are as indicated.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts